## Abstract Parkinson's disease (PD) is a common neurodegenerative disorder of adulthood characterized clinically by rigidity, bradykinesia, resting tremor, and postural instability. The annual incidence of PD ranges between 16 and 19 individuals per 100,000 (Twelves et al., Mov Disord 2003;18:19β3
Genetic testing in Parkinson's disease
β Scribed by Aideen McInerney-Leo
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 65 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
iology was found. Our case documents the occurrence of this unusual myoclonus physiology in biopsy-proven Lafora disease. Indeed, the movement disorder neurophysiology evaluation was more useful in terms of defining a myoclonus physiology than routine EEG.
Wilkins and colleagues 4 first described this myoclonus physiology in 1985. They reported 11 cases, with varying syndrome diagnoses without histologic confirmation, showing small amplitude, multifocal myoclonus of the hands and fingers. 4 They described two patterns, one of EEG bifrontal/ bifrontocentral cerebral negativity of long duration (100 -250 msec) and of variable premyoclonus onset of 5 to 500 msec with some occurrence of bisynchronous myoclonus EMG discharges. 4 The second pattern described was a bifrontal negativity of 30-to 100-msec duration with a premyoclonus onset of 40 to 60 msec. The back-averaged EEG discharge of the patient presented here more closely resembled the first pattern. Like our patient, none of these patients had reflex myoclonus. It is believed that primary generalized epileptic myoclonus is a fragment of primary generalized epilepsy and that subcortical influences may play a part in producing the bilateral EEG discharge. 5
π SIMILAR VOLUMES
## Abstract Myocardial ^123^Metaiodobenzylguanidine (MIBG) enables the assessment of postganglionic sympathetic cardiac innervation. MIBG uptake is decreased in nearly all patients with Parkinson's disease (PD). Our objective was to evaluate MIBG uptake in patients with genetic PD. We investigated